Curé H - Search Results

1

[Therapeutic potential of melatonin in cancer treatment].

Abrial C, Kwiatkowski F, Chevrier R, Gachon F, Curé H, Chollet P. Abrial C, et al. Among authors: cure h. Pathol Biol (Paris). 2005 Jun;53(5):265-8. doi: 10.1016/j.patbio.2004.12.009. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939135 Review. French.

2

[Is there a circadian rhythm of interleukin 15 in humans?].

Chevalier V, Gachon F, Kwiatkowski F, Papon J, Curé H, Doly M, Madelmont JC, Chollet P. Chevalier V, et al. Among authors: cure h. Pathol Biol (Paris). 2003 Jun;51(4):194-6. doi: 10.1016/s0369-8114(03)00044-0. Pathol Biol (Paris). 2003. PMID: 12852986 French.

3

[Modeling 5-FU clearance during a chronomodulated infusion].

Kwiatkowski F, Chevalier V, Chevrier R, Richard D, Cure H, Chollet P. Kwiatkowski F, et al. Among authors: cure h. Pathol Biol (Paris). 2003 Jun;51(4):231-3. doi: 10.1016/s0369-8114(03)00039-7. Pathol Biol (Paris). 2003. PMID: 12852999 French.

4

[Stress, cancer and circadian rhythm of melatonin].

Kwiatkowski F, Abrial C, Gachon F, Chevrier R, Curé H, Chollet P. Kwiatkowski F, et al. Among authors: cure h. Pathol Biol (Paris). 2005 Jun;53(5):269-72. doi: 10.1016/j.patbio.2004.12.018. Epub 2005 Jan 20. Pathol Biol (Paris). 2005. PMID: 15939136 Review. French.

5

Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at Centre Jean Perrin.

Mouret-Reynier MA, Abrial CJ, Ferrière JP, Amat S, Curé HD, Kwiatkowski FG, Feillel VA, Lebouëdec G, Penault-Llorca FM, Chollet PJ. Mouret-Reynier MA, et al. Clin Breast Cancer. 2004 Oct;5(4):303-7. doi: 10.3816/cbc.2004.n.035. Clin Breast Cancer. 2004. PMID: 15507178 Clinical Trial.

6

Assessment of circadian rhythms by actimetry in healthy subjects and patients with advanced colorectal cancer.

Chevalier V, Mormont MC, Curé H, Chollet P. Chevalier V, et al. Among authors: cure h. Oncol Rep. 2003 May-Jun;10(3):733-7. Oncol Rep. 2003. PMID: 12684651

7

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.

Chollet P, Abrial C, Tacca O, Mouret-Reynier MA, Leheurteur M, Durando X, Curé H. Chollet P, et al. Among authors: cure h. Clin Breast Cancer. 2006 Oct;7(4):336-8. doi: 10.3816/CBC.2006.n.047. Clin Breast Cancer. 2006. PMID: 17092402

8

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy.

Tacca O, Penault-Llorca F, Abrial C, Mouret-Reynier MA, Raoelfils I, Durando X, Achard JL, Gimbergues P, Curé H, Chollet P. Tacca O, et al. Among authors: cure h. Oncologist. 2007 Jun;12(6):636-43. doi: 10.1634/theoncologist.12-6-636. Oncologist. 2007. PMID: 17602055 Free article.

9

Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer.

Cure H, Chevalier V, Pezet D, Bousquet J, Focan C, Levi F, Garufi C, Chipponi J, Chollet P. Cure H, et al. Anticancer Res. 2000 Nov-Dec;20(6C):4649-53. Anticancer Res. 2000. PMID: 11205195 Clinical Trial.

10

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.

Amat S, Bougnoux P, Penault-Llorca F, Fétissof F, Curé H, Kwiatkowski F, Achard JL, Body G, Dauplat J, Chollet P. Amat S, et al. Among authors: cure h. Br J Cancer. 2003 May 6;88(9):1339-45. doi: 10.1038/sj.bjc.6600916. Br J Cancer. 2003. PMID: 12778058 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters